Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: An open-label, non-inferiority, randomised controlled trial

Shyam Sundar*, Prabhat Kumar Sinha, Madhukar Rai, Deepak Kumar Verma, Kumar Nawin, Shanawwaj Alam, Jaya Chakravarty, Michel Vaillant, Neena Verma, Krishna Pandey, Poonam Kumari, Chandra Shekhar Lal, Rakesh Arora, Bhawna Sharma, Sally Ellis, Nathalie Strub-Wourgaft, Manica Balasegaram, Piero Olliaro, Pradeep Das, Farrokh Modabber

*Corresponding author for this work

    Research output: Contribution to journalArticleResearchpeer-review

    269 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: An open-label, non-inferiority, randomised controlled trial'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science